Effect of Resistant Starch (Type-4) on Metabolic Syndrome

Sponsor
South Dakota State University (Other)
Overall Status
Completed
CT.gov ID
NCT01887964
Collaborator
(none)
86
1
2
7
12.2

Study Details

Study Description

Brief Summary

Metabolic syndrome is a condition characterized by excess body weight, large waist circumference, high cholesterol and glucose in the blood, and hypertension. People with metabolic syndrome are at increased risk for heart diseases. Research shows benefits of regular fiber intake in metabolic syndrome. However, due to altered taste and texture of the high fiber foods, long term intake of fiber is a challenge for metabolic syndrome patients. This study is designed to find if blinded-substitution of regular wheat flour in domestic kitchen with wheat flour enriched by an adaptable type of fiber (resistant starch-4), minimizes metabolic syndrome symptoms. this special type of fiber is also obtained from wheat.

Condition or Disease Intervention/Treatment Phase
  • Other: RS4 enriched flour
  • Other: Control flour
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
86 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Prevention
Official Title:
Dietary Fiber Intervention in Hutterite Population of South Dakota With and Without Signs of Metabolic Syndrome
Study Start Date :
Mar 1, 2012
Actual Primary Completion Date :
Oct 1, 2012
Actual Study Completion Date :
Oct 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Other: Community-1

Received control flour first and then Resistant starch type 4 (RS4) flour

Other: RS4 enriched flour
Wheat flour with 30% resistant starch (type-4)

Other: Control flour
Wheat flour without resistant starch (type-4)

Other: Community-2

Received RS4 flour first and then control flour

Other: RS4 enriched flour
Wheat flour with 30% resistant starch (type-4)

Other: Control flour
Wheat flour without resistant starch (type-4)

Outcome Measures

Primary Outcome Measures

  1. Changes in metabolic syndrome risk components [26 weeks]

Secondary Outcome Measures

  1. Changes in anthropometric outcomes [26 weeks]

    Body weight, body mass index, systolic and diastolic blood pressure, fat mass and fat-free mass

  2. Changes in blood lipid profile [26 weeks]

    total cholesterol, LDL cholesterol, HDL cholesterol, non-HDL cholesterol and triglycerides

  3. Changes in blood glucose indices [26 weeks]

    fasting blood glucose, postprandial blood glucose and Hemoglobin-A1C

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Any individual aged 18-80 years
Exclusion Criteria:
  • Pregnant

  • Lactating

  • Requires special diets or dietary regimens

  • On long term antibiotic therapy

  • Diagnosed with gastrointestinal diseases (Irritable Bowel syndrome, Crohn's disease or Colitis)

  • Immune compromised

  • Have cancer

Contacts and Locations

Locations

Site City State Country Postal Code
1 South Dakota State University Brookings South Dakota United States 57007

Sponsors and Collaborators

  • South Dakota State University

Investigators

  • Principal Investigator: Moul Dey, PhD, South Dakota State University
  • Principal Investigator: Bonny Specker, PhD, South Dakota State University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Moul Dey, Associate Professor, South Dakota State University
ClinicalTrials.gov Identifier:
NCT01887964
Other Study ID Numbers:
  • 1112012-CR
First Posted:
Jun 27, 2013
Last Update Posted:
Sep 27, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Moul Dey, Associate Professor, South Dakota State University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 27, 2021